• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Cancer Stem Cell Trends Product Image

Cancer Stem Cell Trends

  • ID: 2775580
  • January 2014
  • 23 Pages
  • Global Industry Analysts, Inc

The report illustrates on the growing market for Cancer Stem Cells (CSCs) in the US and Europe The major factors stimulating the growth of the market are the rising affliction of diseases such as cancer and the reimbursement assistance by regulatory organizations in developed nations including the US and Europe. Cancer Stem Cells (CSCs) are the cells within a tumor that possess the capability of self-renewal and driving tumorigenesis. In the previous research studies, rare CSCSs have been isolated from several human tumors such as brain, breast, colon and haematopoietic cancers. CSCs are believed to survive in tumors as a completely distinct population and might cause metastasis and relapse by producing new tumors.

In addition, the report highlights the exponential rise in research on Cancer Stem Cells (CSCs), and the design of novel drugs to treat CSCs. Major players in the field include Boston Biomedical Inc., Macrogenics, and Verastem, Inc.

Note: Product cover images may vary from those shown

CSC Hypothesis
An Overview
Impact on Pharmacology Research and Modern Molecular Physiology
Limitations and Inconsistencies
Origin of CSCs Remains Elusive
CSC In Vitro Models
Cells from Tumor Lines
Genetic Manipulation of Cell Lines
Sorted Tumor Cells Selection
Properties of CSCs
Identification and Characterization of CSCs
Elimination of CSCs - The Key in Preventing Tumor Reappearance

Research on Cancer Stem Cell Accelerates
Existence of CSCs - A Topic of Debate
Hype Surrounding CSC Research Fails to Fetch End Results
Mathematical Models
Cellular Pathways
CSCs and the Wnt Pathway
Focal Adhesion Kinase (FAK)
Future of CSC Research

Cancer Stem Cells and Circulating Tumor Cells Market

Boston Biomedical, Inc. (USA)
Macrogenics (USA)
Verastem, Inc. (USA)

Bionomics Acquires Eclipse Therapeutics
Dainippon Sumitomo Pharma Acquires Boston Biomedical
Queensland University Scientists to Study Ovarian CSCs
Sanford-Burnham Researchers Study Isolated Ovarian CSCs
Harvard Medical School Researchers Suspect Radiotherapy and Chemotherapy in Development of CSCs
Mount Sinai School of Medicine Leads Research on CSCs to Develop New Therapies
University of Texas Scientists Research to Arrest Cancer Re- growth
McMaster's Stem Cell and Cancer Research Institute Scientists Discover Thioridazine’s Potential to Kill CSCs
Ohio State University College of Medicine Proposes Cancer Stem Cells (CSCs) Theory
Research Collaboration Identifies Potential of Gamma-Tocotrienol
Research on Maintenance Mechanism by Cancers
Verastem to Develop Drugs Targeting Cancer Stem Cells
University of Michigan Researchers Study the Role of Cancer Stem Cells in Ovarian Cancer
Hong Kong Researchers Find CSCs with CD24 Surface Protein Aggravate Liver Cancer
CRUK to Research on Cancer-Combating Drugs
University of Michigan Researchers Use Experimental Drugs to Inhibit Breast Cancer
University of Pittsburgh Researchers Discover Prevention of Isolated CSCs from Differentiating


Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown


Our Clients

Amgen Inc. Bayer AG Bio-Rad Laboratories, Inc. Beckman Coulter, Inc. Novartis AG Baxter International Inc.